# Developing and Evaluating a Fully Integrated Treatment Program for Comorbid Social Anxiety and Alcohol Use Disorders

> **NIH NIH R34** · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2020 · $102,468

## Abstract

Abstract
Social anxiety disorder and alcohol use disorder commonly co-occur, and are associated with significant
impairment. The primary aims of the study for which an administrative supplement is being requested were to
develop and evaluate a fully integrated behavioral intervention for comorbid social anxiety disorder and alcohol
use disorder. In the first year of the project, we successfully developed an Intensive Outpatient Program (IOP)
level of care group intervention to be delivered by community-based substance use disorder (SUD) specialty
clinicians. The fully integrated treatment (FIT) combines principles and strategies of exposure-based cognitive
behavioral therapy (CBT) for social anxiety disorder with the Matrix Model approach to the treatment of addiction
(i.e., combining CBT and 12-step facilitation). Thus, Aim 1 has been completed. We have begun to evaluate its
effectiveness in this real-world setting, in which adult treatment seekers with comorbid social anxiety and alcohol
use disorders are randomized to (a) FIT IOP or (b) Matrix Model IOP for twelve weeks, and are assessed at
baseline, mid-treatment, post-treatment, and a 6-month follow-up on engagement (Aim 2), and on alcohol use
and social anxiety outcomes (Aim 3). The COVID-19 pandemic has led to a shut-down of the IOP program,
group services, and any in-patient visits at the clinic site, for an indefinite period of time in Los Angeles. In-person
visits for this type of research are also currently prohibited by the UCLA Vice Chancellor of Research. As a
consequence, recruitment has halted, and we have managed only to provide remote sessions with the remaining
patients who were already enrolled in the study, which is not in the spirit of our intervention that focuses on using
the group as a platform for social anxiety exposure therapy. Moreover, even if we could do some assessments
remotely (though others may not be possible), few patients are seeking remote services at the clinic currently
and thus the pace of recruitment would not allow us to meet our project goals. Therefore, we are anticipating
significant delays in completing our recruitment and enrollment goals, which are necessary for achieving
sufficient statistical power to detect effects between two active treatments. In sum, we are unable to complete
Aims 2 and 3 without supplemental funds. The supplemental funds would support the project coordinator, a
graduate student researcher, and the Principal Investigator for the additional time needed to carry out the study;
and importantly, would fund the clinicians and administrators at the community clinic who carry out their clinical
services and referral/recruitment services that enable us to proceed with the clinical trial. Given the uncertainty
of the shut-down of research and clinical operations, this supplement would enable us to provide salary coverage
for staff to continue their work once we can resume activity.

## Key facts

- **NIH application ID:** 10164494
- **Project number:** 3R34AA025364-03S1
- **Recipient organization:** UNIVERSITY OF CALIFORNIA LOS ANGELES
- **Principal Investigator:** Kate Basia Wolitzky-Taylor
- **Activity code:** R34 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $102,468
- **Award type:** 3
- **Project period:** 2017-05-20 → 2021-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10164494

## Citation

> US National Institutes of Health, RePORTER application 10164494, Developing and Evaluating a Fully Integrated Treatment Program for Comorbid Social Anxiety and Alcohol Use Disorders (3R34AA025364-03S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10164494. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*